What We're Reading: Groups Join ACA Defense; Stem Cell Treatments; Measles Surge
The American Medical Association and the AARP issue briefs in defense of the Affordable Care Act (ACA), while President Trump is delaying an ACA alternative until after the 2020; top hospitals offer unproven stem cell treatments; the measles outbreak hits a new high.
What We're Reading: Medicaid Work Rules; Suicide Risk in Managed Care; Eradicating TB
CMS approves Utah Medicaid work requirements after a federal judge overturns rules for Arkansas and Kentucky; youth suicide risk in Missouri grows with the shift to managed care; CDC says a goal of eliminating tuberculosis by end of 21st century unlikely.
What We're Reading: Idaho Halts Medicaid Bill; FDA and Bone Density; Trump on Healthcare
An Idaho Senate committee killed a bill that would implement Medicaid work requirements in the state; the FDA is proposing requiring that women receive information on their breast density after a mammogram; and President Trump will reportedly submit a healthcare plan to Congress this year.
What We're Reading: New Healthcare Giant; Monsanto Lawsuit; Organ Transplants From Donor with HIV
Insurer Centene strikes a deal to acquire WellCare, creating a new giant in the healthcare market; a federal jury orders Monsanto to pay over $80 million to a plaintiff whose cancer was found to be caused by a common weed killer; surgeons perform a transplant using a kidney from a living donor with HIV.
What We're Reading: Dispute Over ACA Move; Opioid Settlement; Unvaccinated Minors Banned
HHS Secretary Alex Azar and Attorney General Bill Barr opposed the Trump administration’s support to overturn the Affordable Care Act (ACA) through a federal lawsuit; OxyContin maker Purdue Pharma and its owners, the Sackler family, agreed to pay $270 million to avoid a state court trial in Oklahoma over the company’s role in the spread of opioids over the past 20 years; a New York county is banning unvaccinated children in public places in the wake of a measles crisis that has infected more than 150 people.
What We're Reading: Xarelto Settlement; Insulin Hearings; Soda Taxes
Johnson & Johnson and Bayer, who jointly sell the blood thinner drug Xarelto, settled lawsuits that claimed the companies failed to warn about potentially fatal side-effects for $775 million; the Oversight and Investigations Subcommittee of the House Energy and Commerce Committee have planned hearings in the coming weeks over the rising cost of insulin; the American Academy of Pediatrics and the American Heart Association called for taxes, warning labels, and advertising curbs on soda in hopes to reduce consumption among children and adolescents.
What We're Reading: EHR Oversight; Medicaid Expansion and CRC; Arkansas Work Requirements
FDA Commissioner Scott Gottlieb, MD, called for stricter oversight of electronic health records (EHRs); Medicaid expansion in Kentucky has led to increases in screening, diagnoses, and survival of colorectal cancer (CRC); contradicting claims from some federal and state officials, the majority of beneficiaries who lost coverage for not complying with Arkansas’ Medicaid work requirements have not found employment.
What We're Reading: Type of Dementia Matters; Eggs and Heart Health; Abortion Bill in Maine
While Alzheimer disease and other brain diseases are similar and cannot be stopped, it's important that families get the right diagnosis in order to get the best care and plan for the future; daily consumption of eggs has been found to slightly increase the risk of heart disease and early mortality; Maine Governor Janet Mills submitted a bill to allow abortions to be performed by medical professionals besides physicians.
What We're Reading: Dementia Mortality; Purdue's Opioid Antidote; Prior Authorization Frustration
Between 2000 and 2007, mortality due to dementia more than doubled; the FDA has granted fast-track designation for an opioid antidote from Purdue Pharma, the pharmaceutical company accused of aggressively marketing OxyContin; physicians say prior authorization is interfering with continuity of care.
What We're Reading: Gene Editing Moratorium; e-Cigarette Sales; PBMs Invited to Drug Price Hearing
An international group of scientists has called for a global moratorium on gene-edited babies; proposed guidance would limit the sale of flavored e-cigarettes; and the Senate has invited executives from 5 pharmacy benefit managers (PBMs) to testify at a hearing on drug prices.
What We're Reading: Fees for e-Cigarette Industry; Printing Skin; Medieval Diseases on the Rise
Trump administration proposes fees on e-cigarette industry to fund FDA regulatory oversight; Scientists create bioprinter that allows creation of new skin to treat wounds; Medieval era diseases reappear in unsanitary locations among homeless populations and others.
What We're Reading: Robotic Surgery Questioned; Migrants Quarantined; Medicaid and Sex Reassignment
Robotic surgery remains a widespread practice for cancer treatment while the FDA warns no evidence has been found linking these procedures to safer patient outcomes; more than 2000 migrants in US detention centers quarantined as reported cases of mumps arise; Iowa Supreme Court rules that Medicaid can not deny coverage for sex reassignment surgery.
What We're Reading: Home Care for Dialysis; Title X Lawsuit; Addressing Veteran Suicide
The Trump administration is working on a payment model that would favor home dialysis over in-clinic treatment for kidney disease; California is suing the Trump administration over rule changes to Title X; Trump has ordered the creation of a task force to address veteran suicide.
Exhaled Breath Condensate Containing Ultrafine Particles Marks COPD Damage
A recent study measured exhaled breath condensate (EBC) content that contained ultrafine particles (UFP) as a reflection of inflammation and oxidative stress in patients with chronic obstructive pulmonary disease (COPD) and as a marker of exacerbations.
What We're Reading: Flu Shot During Pregnancy; Liquid Biopsy for NSCLC; Physician-Generated Revenue
Researchers have confirmed that there is no link between flu shots and miscarriages; a liquid biopsy is as effective as tissue-based testing for identifying treatment for lung cancer; and physicians generate an average of $2 million a year for hospitals.